|
Volumn 376, Issue 21, 2017, Pages 2092-2093
|
Anti-interleukin-31 receptor a antibody for atopic dermatitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOKINE RECEPTOR;
GLUCOCORTICOID;
INTERLEUKIN 31;
INTERLEUKIN 31 RECEPTOR A;
NEMOLIZUMAB;
UNCLASSIFIED DRUG;
ANTIBODY;
INTERLEUKIN DERIVATIVE;
ATOPIC DERMATITIS;
BODY SURFACE;
DISEASE SEVERITY;
DRUG EFFICACY;
ECZEMA AREA AND SEVERITY INDEX SCORE;
HUMAN;
LETTER;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PRURITUS;
SCORING SYSTEM;
TREATMENT DURATION;
ECZEMA;
IMMUNOLOGY;
ANTIBODIES;
DERMATITIS, ATOPIC;
ECZEMA;
HUMANS;
INTERLEUKINS;
|
EID: 85019848082
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1704013 Document Type: Letter |
Times cited : (33)
|
References (1)
|